Latest News, Updates & Breaking Headlines
Mumbai, Apr 27 (ANI): Chairman of Sun Pharma Management Dilip Shanghvi speaks during a press conference at Worli, in Mumbai on Monday. (ANI Photo) New Delhi: In its boldest move yet, Sun Pharma, India’s largest pharma company, has struck the biggest-ever overseas pharma deal, acquiring US-listed Organon & Co for $11.8 billion (Rs 98,000 crore)…
Sun Pharmaceutical Industries on Monday announced it will acquire US-based Organon & Co. in an all-cash deal valued at $11.75 billion, marking one of the largest overseas acquisitions by an Indian company.Under the definitive agreement, Sun Pharma will buy all outstanding shares of Organon at $14 per share.The deal, approved by the boards of both…
NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs, pharma…
Hyderabad: Aurobindo Pharma’s board on Monday approved a Rs 800 crore share proposal to buy back up to 54.23 lakh fully paid-up equity shares of the company of face value Rs 1 each at Rs 1,475 a share.The proposed buyback, which is subject to regulatory and statutory approvals, represents up to 0.93% of the total…
India’s pharmaceutical exports remained on a growth track in the last financial year despite global headwinds, crossing $28 billion during April–February FY26, while industry leaders said the sector is on course to nearly double in size to $130 billion by 2030.Speaking at the inaugural session of the ‘Chintan Shivir: Scaling Up Pharma Exports’ on Saturday,…
A year after US President Donald Trump’s “Liberation Day” tariffs shook global markets, Washington is back with another round, this time targeting drug and metal imports. The earlier tariffs, announced on April 2 last year, had sent ripples across major financial markets as investors assessed their impact. Now, the US has unveiled fresh measures on…
NEW DELHI: The Centre has warned pharmaceutical companies against promoting prescription weight-loss GLP-1 drugs – popularly sold under brand names Ozempic, Wegovy and Mounjaro – through advertisements or “disease awareness” campaigns that indirectly encourage their use among the public.In an advisory, Central Drugs Standard Control Organisation said it had come to its notice that some…
NEW DELHI: There was a time when some of India’s leading banking and financial services firms had women at the helm, making these sectors a visible symbol of gender diversity. Today, that centre of gravity has shifted.Consumer-facing industries and pharmaceuticals have emerged as the new strongholds for women CEOs, reflecting where long-standing leadership pipelines are…
Hyderabad: India’s pharmaceutical sector is staring at potential losses of Rs 2,500– Rs 5,000 crore if March exports to the Gulf Cooperation Council (GCC) and the wider West Asia and North Africa (WANA) are completely disrupted by the ongoing West Asia conflict, which is intensifying pressure on freight, shipping routes, and delivery schedules, according to…
India’s pharmaceutical exports rose 9.4 per cent in 2024–25 to $30.47 billion, with the industry targeting double-digit growth in 2026–27 amid efforts to expand global market access, the commerce ministry said on Saturday, PTI reported. Issues related to pharmaceutical exports were discussed during a Chintan Shivir held in Ahmedabad between government officials and industry representatives,…
